All Stories

  1. Comparing the pharmacokinetics of adalimumab originator and biosimilar product in patients with Inflammatory bowel disease or autoimmune disease

    Article • Saudi Pharmaceutical Journal, March 2026, Springer Science + Business Media

    Dr. Mohamed Omar Saad

  2. Effect of RAS Pathway Gene Mutations on Survival in Myelodysplastic Syndrome: A Systematic Review and Meta-Analysis

    Article • Cancer Control, February 2026, SAGE Publications

    Nabil E. Omar, Dr. Mohamed Omar Saad

  3. Derivation and Validation of a Genotype- Guided Warfarin Dosing Model in a Mixed Arab Population

    Article • Clinical and Applied Thrombosis/Hemostasis, January 2026, SAGE Publications

    Dr. Mohamed Omar Saad

  4. Safety of immune checkpoint inhibitors for cancer treatment: real-world retrospective data analysis from Qatar (SAFE-ICI-Q study)

    Article • Frontiers in Immunology, October 2025, Frontiers

    Assoc. Prof Shereen Elazzazy , Dr. Mohamed Omar Saad

  5. Global, regional, and national sepsis incidence and mortality, 1990–2021: a systematic analysis

    Article • The Lancet Global Health, October 2025, Elsevier

    Dr Syed Muhammad Yousaf Farooq, Asrat Agalu Abejew, Mesfin Abebe, Felix Nyande, Kamoru Ademola Adedokun, Dr. Mahmoud Nassar, Dr Mohammed Kuddus, Dr. Najim Z. Alshahrani, Dr. Mohamed Omar Saad, Javad Javidnia

  6. Association Between Polyethylene Glycol Dose and Length of Hospital Stay in Body Packing Patients: A Retrospective Review

    Article • Emergency Care and Medicine, August 2025, MDPI AG

    Dr. Mohamed Omar Saad

  7. Enoxaparin dosing for venous thromboembolism prophylaxis in hospitalized underweight adult patients: a retrospective cohort study

    Article • Thrombosis Journal, May 2025, Springer Science + Business Media

    Dr. Mohamed Omar Saad

  8. Safety of Different Weight-Based Dosing Strategies of Intravenous Acyclovir in Obese Patients: A Retrospective Cohort Study

    Article • Annals of Pharmacotherapy, February 2025, SAGE Publications

    Dr. Mohamed Omar Saad

  9. 577P A real-world analysis of immune checkpoint inhibitors outcomes in patients with baseline auto-immune diseases

    Article • Annals of Oncology, December 2024, Elsevier

    Dr. Mohamed Omar Saad, Assoc. Prof Shereen Elazzazy

  10. Accuracy of an internationally validated genetic-guided warfarin dosing algorithm compared to a clinical algorithm in an Arab population

    Article • Current Problems in Cardiology, December 2024, Elsevier

    Dr. Mohamed Omar Saad

  11. 571P The economic sequelae of immune related adverse events secondary to immune checkpoints inhibitors in Qatar: A hospital-perspective analysis

    Article • Annals of Oncology, December 2024, Elsevier

    Dr. Mohamed Omar Saad, Assoc. Prof Shereen Elazzazy

  12. Correction: A survey on the knowledge and attitudes of pharmacists towards the application of antimicrobial therapeutic drug monitoring and its challenges in Qatar

    Article • PLOS One, October 2024, PLOS

    Dr. Mohamed Omar Saad

  13. The predictors of successful methotrexate treatment of tubal ectopic pregnancy

    Article • Journal of Obstetrics and Gynaecology, June 2024, Taylor & Francis

    Dr. Mohamed Omar Saad

  14. Clinical versus fixed warfarin dosing and the impact on quality of anticoagulation (The ClinFix trial)

    Article • Clinical and Translational Science, June 2024, Wiley

    Dr. Mohamed Omar Saad

  15. Abbreviated Urine Collection Compared With 24-Hour Urine Collection for Measuring Creatinine Clearance in Adult Critically Ill Patients: A Systematic Review

    Article • Annals of Pharmacotherapy, April 2024, SAGE Publications

    Dr. Mohamed Omar Saad

  16. A survey on the knowledge and attitudes of pharmacists towards the application of antimicrobial therapeutic drug monitoring and its challenges in Qatar

    Article • PLOS One, February 2024, PLOS

    Dr. Mohamed Omar Saad

  17. Efficacy and safety of insulin glargine 300 units/mL vs insulin degludec in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis

    Article • Frontiers in Endocrinology, January 2024, Frontiers

    Dr. Mohamed Omar Saad

  18. Extracorporeal blood purification with Oxiris® filter in critically ill patients with COVID-19 requiring continuous renal replacement therapy

    Article • The International Journal of Artificial Organs, November 2023, SAGE Publications

    Dr. Mohamed Omar Saad

  19. Characteristics and outcomes of adult patients with asthma presenting with COVID-19: A comparative cohort study

    Article • Qatar Medical Journal, September 2023, QScience

    Dr. Mohamed Omar Saad

  20. Virtual Care? Telepharmacy in Critical Care Settings for Patient-Centered Care and Multidisciplinary Collaboration: A Scoping Review of Activities, Benefits, Economic Impact, Challenges, and Knowledge Gaps

    Article • Telemedicine and e-Health, July 2023, Mary Ann Liebert Inc

    Dr. Mohamed Omar Saad

  21. EVALUATION OF HYDROCORTISONE, VITAMIN C, AND THIAMINE FOR THE TREATMENT OF SEPTIC SHOCK: A RANDOMIZED CONTROLLED TRIAL (THE HYVITS TRIAL)

    Article • Shock, March 2023, Wolters Kluwer Health

    Dr. Mohamed Omar Saad

  22. 2022 Global Conference on Clinical Pharmacy October 15 ‐ 18, 2022

    Article • JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, December 2022, Wiley

    Dr. Mohamed Omar Saad

  23. Risk of serotonin syndrome in acutely ill patients receiving linezolid and opioids concomitantly: a retrospective cohort study

    Article • IJID Regions, December 2022, Elsevier

    Dr. Mohamed Omar Saad

  24. Perspectives of clinical pharmacists on the provision of pharmaceutical care through telepharmacy services during COVID-19 pandemic in Qatar: A focus group

    Article • PLOS One, October 2022, PLOS

    Dr. Mohamed Omar Saad

  25. Impact of Early Tracheostomy on Weaning From Ventilation and Sedation in COVID-19 Pregnant and Early Postpartum Patient: Two Case Reports

    Article • Cureus, September 2022, Cureus, Inc.

    Dr. Mohamed Omar Saad

  26. Risk of serotonin syndrome in acutely ill patients receiving linezolid and opioids concomitantly: A retrospective cohort study

    Article • July 2022, Research Square

    Dr. Mohamed Omar Saad

  27. Critical care tele‐pharmacy services during COVID ‐19 pandemic: A qualitative exploration of healthcare practitioners' perceptions

    Article • Journal of Clinical Pharmacy and Therapeutics, June 2022, Hindawi Publishing Corporation

    Dr. Mohamed Omar Saad

  28. Soluble ACE2 and angiotensin II levels are modulated in hypertensive COVID-19 patients treated with different antihypertension drugs

    Article • Blood Pressure, May 2022, Taylor & Francis

    Dr. Mohamed Omar Saad

  29. Burnout among pharmacy professionals in Qatar: A cross-sectional study

    Article • PLOS One, May 2022, PLOS

    Dr. Mohamed Omar Saad

  30. Predictors of mortality and morbidity in critically ill COVID‐19 patients: An experience from a low mortality country

    Article • Health Science Reports, May 2022, Wiley

    Dr. Mohamed Omar Saad

  31. Post-discharge phone follow-up: a collaboration for optimizing medications management upon transition of care

    Article • Journal of Emergency Medicine Trauma and Acute Care, January 2022, QScience

    Dr. Mohamed Omar Saad

  32. Anti-Xa Directed Thromboprophylaxis in Critically Ill Patients with Coronavirus Disease 2019

    Article • Clinical and Applied Thrombosis/Hemostasis, January 2022, SAGE Publications

    Dr. Mohamed Omar Saad

  33. Clinical outcomes of intravenous immunoglobulin therapy in COVID-19 related acute respiratory distress syndrome: a retrospective cohort study

    Article • BMC Pulmonary Medicine, November 2021, Springer Science + Business Media

    Dr. Mohamed Omar Saad

  34. Clinical outcomes of intravenous immunoglobulin therapy in COVID-19 related acute respiratory distress syndrome: a retrospective cohort study

    Article • May 2021, Research Square

    Dr. Mohamed Omar Saad

  35. Unfractionated heparin as a safe alternative in a case of low molecular weight heparin-induced thrombocytosis: A case report

    Article • Annals of Medicine and Surgery, May 2021, Elsevier

    Dr. Mohamed Omar Saad

  36. Letter to the editor about “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial”

    Article • International Journal of Antimicrobial Agents, January 2021, Elsevier

    Dr. Mohamed Omar Saad

  37. Hyperglycemia Risk Evaluation of Hydrocortisone Intermittent Boluses vs Continuous Infusion in Septic Shock: A Retrospective Study

    Article • Indian Journal of Critical Care Medicine, January 2021, Jaypee Brothers Medical Publishing

    Dr. Mohamed Omar Saad

  38. Mortality incidence among critically ill burn patients infected with multidrug-resistant organisms: A retrospective cohort study

    Article • Scars Burns & Healing, January 2021, SAGE Publications

    Dr. Mohamed Omar Saad

  39. 2020 ACCP Annual Meeting (Virtual) October 19 ‐ 30, 2020

    Article • JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, December 2020, Wiley

    Dr. Mohamed Omar Saad

  40. Evaluation of the risk of acute kidney injury with the use of piperacillin/tazobactam among adult critically ill patients

    Article • Infection, July 2020, Springer Science + Business Media

    Dr. Mohamed Omar Saad

  41. Vancomycin therapeutic drug monitoring service quality indices and clinical effectiveness outcomes: A retrospective cohort and clinical audit

    Article • JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, March 2020, Wiley

    Dr. Mohamed Omar Saad

  42. 2019 ACCP Annual Meeting

    Article • JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, February 2020, Wiley

    Dr. Mohamed Omar Saad

  43. Torsemide versus furosemide after acute decompensated heart failure: a retrospective observational study

    Article • BMC Cardiovascular Disorders, May 2019, Springer Science + Business Media

    Dr. Mohamed Omar Saad

  44. Lansoprazole-Induced Thrombocytopenia in a Critically Ill Patient: A Case Report

    Article • Journal of Pharmacy Practice, March 2019, SAGE Publications

    Dr. Mohamed Omar Saad

  45. Clinical and Pharmacokinetic Outcomes of Peak–Trough-Based Versus Trough-Based Vancomycin Therapeutic Drug Monitoring Approaches: A Pragmatic Randomized Controlled Trial

    Article • European Journal of Drug Metabolism and Pharmacokinetics, March 2019, Springer Science + Business Media

    Dr. Mohamed Omar Saad

  46. Preemptive Dose Adjustment Effect on the Quality of Anticoagulation Management in Warfarin Patients With Drug Interactions: A Retrospective Cohort Study

    Article • Clinical and Applied Thrombosis/Hemostasis, January 2019, SAGE Publications

    Dr. Mohamed Omar Saad

  47. Effectivness of Clonidine in Treating Dexmedetomidine Withdrawal in a Patient with Co-Existing Psychiatric Illness: A Case Report

    Article • American Journal of Case Reports, July 2018, International Scientific Literature

    Dr. Mohamed Omar Saad

  48. Short versus regular-course antimicrobial therapy for intraabdominal infections

    Article • International Journal of Pharmacy Practice, January 2017, Wiley

    Dr. Mohamed Omar Saad

  49. Implementation of “CODE SEPSIS” for septic patients at Al Wakra Hospital: A practice improvement initiative

    Article • Journal of Emergency Medicine Trauma and Acute Care, October 2016, QScience

    Dr. Mohamed Omar Saad

  50. Impact of clinical pharmacy services in a short stay unit of a hospital emergency department in Qatar

    Article • International Journal of Clinical Pharmacy, March 2016, Springer Science + Business Media

    Dr. Mohamed Omar Saad

  51. Abstracts and Index of Authors

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, October 2013, Wiley

    Dr John M Allen, Dr. Mohamed Omar Saad